Yahoo India Web Search

Search results

1. www.researchgate.net › profile › Yasuhiro-Ito-2Yasuhiro ITO | Kuma Hospital, Kobe | Department of Surgery of ...

   www.researchgate.net › profile › Yasuhiro-Ito-2

   Apr 8, 2020 · Yasuhiro Ito. Akira Miyauchi. Active surveillance for low-risk papillary thyroid microcarcinoma (PTMC; T1aN0MI) was initiated at Kuma Hospital, Kobe, Japan, in 1993, based on a proposal by...

2. www.sony.com › en › SonyInfoSony Group Portal - Sony Group Corporation Executive Changes

   www.sony.com › en › SonyInfo

   • Cached

   Feb 2, 2023 · Yasuhiro Ito (Newly appointed) Senior Vice President In charge of Human Resources *1 Sony AI plans to change its company name to Sony Research Inc. as of April 1, 2023. *2 Tsuyoshi Kodera will be concurrently appointed to Chief Information Officer (CIO) as of July 1, 2023.

3. Images

   • 
   • 
   • 
   • 
   • 

   View all

4. loop.frontiersin.org › people › 59108Loop | Yasuhiro Ito

   loop.frontiersin.org › people › 59108

   Jan 1, 2014 · Yasuhiro Ito is a medical director of Kuma Hospital, Kobe, Japan. He started his carrier of thyroid surgeon and research of thyroid carcinoma in 2001. He published over 200 manuscripts to international journals mainly in the field of clinical studies of thyroid carcinoma.

5. pubmed.ncbi.nlm.nih.gov › 32269182The revised clinical practice guidelines on the management of ...

   pubmed.ncbi.nlm.nih.gov › 32269182

   Jul 28, 2020 · The Japan Associations of Endocrine Surgeons has developed the revised version of the Clinical Practice Guidelines for Thyroid Tumors. This article describes the guidelines translated into English for the 35 clinical questions relevant to the therapeutic management of thyroid cancers.

   • Author: Yasuhiro Ito, Naoyoshi Onoda, Takahiro Okamoto

   • Publish Year: 2020

6. pubmed.ncbi.nlm.nih.gov › 37287648Active Surveillance May Be the Best Initial Management for ...

   pubmed.ncbi.nlm.nih.gov › 37287648

   May 16, 2023 · Active surveillance for low-risk papillary thyroid microcarcinoma (PTMC; T1aN0MI) was initiated at Kuma Hospital (Kobe, Japan) in 1993, based on a proposal by Akira Miyauchi. Favorable outcomes of such surveillance have been reported.

7. pubmed.ncbi.nlm.nih.gov › 33224844Active surveillance of low-risk papillary thyroid microcarcinomas

   pubmed.ncbi.nlm.nih.gov › 33224844

   Yasuhiro Ito 1 , Akira Miyauchi 1. Affiliation. 1 Department of Surgery, Kuma Hospital, Kobe, Japan. PMID: 33224844. PMCID: PMC7667125. DOI: 10.21037/gs-2019-catp-03. Abstract. In 1993, active surveillance of low-risk papillary thyroid microcarcinomas (PTMCs) started in Kuma Hospital, Kobe, Japan.

   • Author: Yasuhiro Ito, Akira Miyauchi

   • Publish Year: 2020

8. pubmed.ncbi.nlm.nih.gov › 30051240Static Prognostic Factors and Appropriate Surgical Designs ...

   pubmed.ncbi.nlm.nih.gov › 30051240

   Yasuhiro Ito 1 , Akira Miyauchi 2 , Minoru Kihara 2 , Takuya Higashiiyama 2 , Mitsuhiro Fukushima 2 , Akihiro Miya 2. Affiliations. 1 Department of Surgery, Kuma Hospital, 8-2-35, Shimoyamate-dori, Chuo-ku, Kobe, Hyogo, 650-0011, Japan. ito01@kuma-h.or.jp.